Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria
- 1 September 1995
- journal article
- research article
- Published by Wiley in Parasite Immunology
- Vol. 17 (9), 493-501
- https://doi.org/10.1111/j.1365-3024.1995.tb00920.x
Abstract
The prevalence and concentration of naturally acquired humoral response (IgG) to merozoite surface protein 2 (MSP2), RESA, SPf66 and crude schizont extract were measured in a population living in a malaria highly endemic area of Papua New Guinea. A prospective longitudinal study in 0.5-15 year old children was conducted for one year in order to examine the relationship between the humoral response to these antigens and subsequent susceptibility to clinical malaria using a series of clinical definitions. The prevalence and concentration of antibodies to all antigens increased with age. Such correlation with age was most marked for MSP2 recombinant proteins. When age and previous exposure were controlled for, only antibody levels to MSP2 recombinant proteins (3D7 and d3D7) and to RESA predicted a reduction in incidence rate of episodes of clinical malaria. Our results support the inclusion of the recombinant proteins of the 3D7 allelic family of merozoite surface antigen 2 and RESA into a subunit vaccine against malaria.Keywords
This publication has 36 references indexed in Scilit:
- Plasmodium falciparum: Extensive Polymorphism in Merozoite Surface Antigen 2 Alleles in an Area with Endemic Malaria in Papua New GuineaExperimental Parasitology, 1994
- Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in ColombiaThe Lancet, 1993
- In human malaria protective antibodies are directed mainly against the Lys‐Glu ion pair within the Lys‐Glu‐Lys motif of the synthetic vaccine SPf 66Parasite Immunology, 1992
- Association between immune recognition of the malaria vaccine candidate antigen Pf155/RESA and resistance to clinical disease: a prospective study in a malaria-endemic region of West AfricaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1991
- Longitudinal study of seroreactivities to Pf 155/RESA and its repetitive sequences in small children from a holoendemic area of LiberiaParasite Immunology, 1991
- Relationships between clinical protection and antibodies to Plasmodium falciparum RESA (Ring-infected Erythrocyte Surface Antigen) peptidesInternational Journal for Parasitology, 1991
- Studies on the humoral immune response to a synthetic vaccine against Plasmodium falciparum malariaClinical and Experimental Immunology, 1991
- Plasmodium falciparum: Gene structure and hydropathy profile of the major merozoite surface antigen (gp195) of the Uganda-Palo Alto isolateExperimental Parasitology, 1988
- A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malariaNature, 1988
- Immunization of Aotus monkeys with recombinant proteins of an erythrocyte surface antigen of Plasmodium falciparumNature, 1986